|
🦁
|
HPV-associated head and neck cancer: a virus-related cancer epidemic.
S. Marur,
G. D’Souza,
W. Westra,
A. Forastiere
|
10 |
2010 |
10
🦁
|
|
🦁
|
Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment.
S. Marur,
A. Forastiere
|
9 |
2016 |
9
🦁
|
|
🦁
|
Head and neck cancer: changing epidemiology, diagnosis, and treatment.
S. Marur,
A. Forastiere
|
9 |
2008 |
9
🦁
|
|
🦁
|
E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group.
19 auth.
S. Marur,
Shuli Li,
A. Cmelak,
M. Gillison,
Weiqiang Zhao,
R. Ferris,
H. William,
Westra,
J. Gilbert,
J. Bauman,
...
L. Wagner,
D. Trevarthen,
Jahagirdar Balkrishna,
A. Barbara,
Murphy,
N. Agrawal,
A. Colevas,
C. Chung,
B. Burtness
|
8 |
2017 |
8
🦁
|
|
🐜
|
Tadalafil Augments Tumor Specific Immunity in Patients with Head and Neck Squamous Cell Carcinoma
22 auth.
J. Califano,
Zubair Khan,
K. Noonan,
Lakshmi Rudraraju,
Zhe Zhang,
Hao Wang,
S. Goodman,
C. Gourin,
P. Ha,
C. Fakhry,
...
J. Saunders,
M. Levine,
M. Tang,
G. Neuner,
J. Richmon,
R. Blanco,
N. Agrawal,
W. Koch,
S. Marur,
D. Weed,
P. Serafini,
I. Borrello
|
7 |
2015 |
7
🐜
|
|
🐬
|
Association between severe treatment‐related lymphopenia and progression‐free survival in patients with newly diagnosed squamous cell head and neck cancer
J. Campian,
G. Sarai,
X. Ye,
S. Marur,
S. Grossman
|
7 |
2014 |
7
🐬
|
|
🐜
|
Randomized safety and efficacy study of fosbretabulin with paclitaxel/carboplatin against anaplastic thyroid carcinoma.
17 auth.
J. Sosa,
R. Elisei,
B. Jarzab,
J. Balkissoon,
Shiao-ping Lu,
C. Bal,
S. Marur,
A. Gramza,
R. B. Yosef,
B. Gitlitz,
...
B. Haugen,
F. Ondrey,
Charles Lu,
S. Karandikar,
F. Khuri,
L. Licitra,
S. Remick
|
7 |
2014 |
7
🐜
|
|
🦁
|
FDA analyses of survival in older adults with metastatic non-small cell lung cancer in controlled trials of PD-1/PD-L1 blocking antibodies.
8 auth.
S. Marur,
H. Singh,
Pallavi S Mishra-Kalyani,
E. Larkins,
P. Keegan,
R. Sridhara,
...
G. Blumenthal,
R. Pazdur
|
6 |
2018 |
6
🦁
|
|
🐜
|
Effect of radiotherapy and chemotherapy on the risk of mucositis during intensity-modulated radiation therapy for oropharyngeal cancer.
11 auth.
G. Sanguineti,
G. Sanguineti,
M. Sormani,
S. Marur,
G. Gunn,
N. Rao,
...
M. Cianchetti,
F. Ricchetti,
T. McNutt,
Binbin Wu,
A. Forastiere
|
6 |
2012 |
6
🐜
|
|
🐬
|
Multidisciplinary head and neck cancer clinic and adherence with speech pathology
Heather M. Starmer,
G. Sanguineti,
S. Marur,
C. Gourin
|
6 |
2011 |
6
🐬
|
|
🐜
|
E1308: Reduced-dose IMRT in human papilloma virus (HPV)-associated resectable oropharyngeal squamous carcinomas (OPSCC) after clinical complete response (cCR) to induction chemotherapy (IC).
14 auth.
Shuli Li,
S. Marur,
Weiqiang Zhao,
W. Westra,
C. Chung,
M. Gillison,
J. Gilbert,
J. Bauman,
L. Wagner,
R. Ferris,
...
D. Trevarthen,
A. Colevas,
B. Jahagirdar,
B. Burtness
|
5 |
2014 |
5
🐜
|
|
🐜
|
Volumetric change of selected organs at risk during IMRT for oropharyngeal cancer.
8 auth.
F. Ricchetti,
Binbin Wu,
T. McNutt,
J. Wong,
A. Forastiere,
S. Marur,
...
Heather M. Starmer,
G. Sanguineti
|
5 |
2011 |
5
🐜
|
